Working… Menu

A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment (RESORT-2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01318837
Recruitment Status : Completed
First Posted : March 21, 2011
Last Update Posted : July 10, 2014
Astellas Pharma Korea, Inc.
Information provided by (Responsible Party):
Astellas Pharma Inc